ProfileGDS4718 / 205642_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 54% 64% 53% 53% 67% 64% 48% 64% 57% 53% 70% 63% 67% 60% 64% 63% 71% 64% 69% 53% 58% 61% 55% 61% 70% 64% 66% 63% 58% 72% 73% 62% 54% 65% 70% 71% 58% 61% 63% 57% 70% 68% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9512757
GSM549102patient 115, normal, homogenized [OPG study]5.7417454
GSM549104patient 119, normal, homogenized [OPG study]6.4461564
GSM549108patient 138, normal, homogenized [OPG study]5.7237953
GSM549119patient 077, normal, homogenized [OPG study]5.676253
GSM549133patient 032, cancer, homogenized [OPG study]6.6392667
GSM549139patient 042, cancer, homogenized [OPG study]6.4286964
GSM549099patient 107, normal, homogenized [OPG study]5.3922748
GSM549109patient 139, normal, homogenized [OPG study]6.3871164
GSM549110patient 046, normal, homogenized [OPG study]5.9138357
GSM549114patient 063, normal, homogenized [OPG study]5.6108753
GSM549122patient 082, normal, homogenized [OPG study]6.9196870
GSM549134patient 033, cancer, homogenized [OPG study]6.3142463
GSM549136patient 036, cancer, homogenized [OPG study]6.6325267
GSM549140patient 044, cancer, homogenized [OPG study]6.1027460
GSM549111patient 047, normal, homogenized [OPG study]6.3836664
GSM549113patient 057, normal, homogenized [OPG study]6.3140263
GSM549132patient 031, cancer, homogenized [OPG study]7.0056471
GSM549137patient 038, cancer, homogenized [OPG study]6.4502364
GSM549142patient 047, cancer, homogenized [OPG study]6.8050869
GSM549100patient 110, normal, homogenized [OPG study]5.713653
GSM549107patient 135, normal, homogenized [OPG study]5.966558
GSM549115patient 068, normal, homogenized [OPG study]6.1561461
GSM549116patient 072, normal, homogenized [OPG study]5.7774355
GSM549120patient 078, normal, homogenized [OPG study]6.2085561
GSM549131patient 030, cancer, homogenized [OPG study]6.9018170
GSM549118patient 074, normal, homogenized [OPG study]6.3843264
GSM549129patient 027, cancer, homogenized [OPG study]6.5888566
GSM549123patient 088, normal, homogenized [OPG study]6.3624963
GSM549124patient 006, cancer, homogenized [OPG study]5.9851958
GSM549126patient 015, cancer, homogenized [OPG study]7.0896272
GSM549128patient 025, cancer, homogenized [OPG study]7.22173
GSM549103patient 117, normal, homogenized [OPG study]6.2667362
GSM549117patient 073, normal, homogenized [OPG study]5.7062254
GSM549138patient 041, cancer, homogenized [OPG study]6.5128665
GSM549141patient 045, cancer, homogenized [OPG study]6.9381270
GSM549130patient 028, cancer, homogenized [OPG study]6.9553171
GSM549101patient 111, normal, homogenized [OPG study]5.9938358
GSM549105patient 128, normal, homogenized [OPG study]6.1989961
GSM549106patient 134, normal, homogenized [OPG study]6.3408763
GSM549112patient 048, normal, homogenized [OPG study]5.9102457
GSM549125patient 011, cancer, homogenized [OPG study]6.8345970
GSM549127patient 024, cancer, homogenized [OPG study]6.7835468
GSM549135patient 035, cancer, homogenized [OPG study]6.1069460